Selected research
Market Analysis & Forecast
Global Angiotensin II Receptor Market Analysis and Forecast 2026-2032
Market perspective
The global Angiotensin II Receptor market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Angiotensin II Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Angiotensin II Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Angiotensin II Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Angiotensin II Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Angiotensin II Receptor include CJ HealthCare Corp, MorphoSys AG, Vicore Pharma AB and Novartis AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Angiotensin II Receptor, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Angiotensin II Receptor, also provides the sales of main regions and countries. Of the upcoming market potential for Angiotensin II Receptor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Angiotensin II Receptor sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Angiotensin II Receptor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Angiotensin II Receptor sales, projected growth trends, production technology, application and end-user industry.
Angiotensin II Receptor Segment by Company
CJ HealthCare Corp
MorphoSys AG
Vicore Pharma AB
Novartis AG
Angiotensin II Receptor Segment by Type
MOR-107
KDT-501
EMA-401
C-21
Others
Angiotensin II Receptor Segment by Application
Women's Health
Immunology
Acute Ischemic Stroke
Respiratory
Others
Angiotensin II Receptor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angiotensin II Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Angiotensin II Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angiotensin II Receptor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Angiotensin II Receptor in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Angiotensin II Receptor manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Angiotensin II Receptor sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- MOR-107
- KDT-501
- EMA-401
- C-21
- Others
Applications
- Women's Health
- Immunology
- Acute Ischemic Stroke
- Respiratory
- Others
Companies covered
- CJ HealthCare Corp
- MorphoSys AG
- Vicore Pharma AB
- Novartis AG
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Angiotensin II Receptor Market by Type
- 1.2.1 Global Angiotensin II Receptor Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 MOR-107
- 1.2.3 KDT-501
- 1.2.4 EMA-401
- 1.2.5 C-21
- 1.2.6 Others
- 1.3 Angiotensin II Receptor Market by Application
- 1.3.1 Global Angiotensin II Receptor Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Women's Health
- 1.3.3 Immunology
- 1.3.4 Acute Ischemic Stroke
- 1.3.5 Respiratory
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Angiotensin II Receptor Market Dynamics
- 2.1 Angiotensin II Receptor Industry Trends
- 2.2 Angiotensin II Receptor Industry Drivers
- 2.3 Angiotensin II Receptor Industry Opportunities and Challenges
- 2.4 Angiotensin II Receptor Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Angiotensin II Receptor Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Angiotensin II Receptor Revenue by Region
- 3.2.1 Global Angiotensin II Receptor Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Angiotensin II Receptor Revenue by Region (2021-2026)
- 3.2.3 Global Angiotensin II Receptor Revenue by Region (2027-2032)
- 3.2.4 Global Angiotensin II Receptor Revenue Market Share by Region (2021-2032)
- 3.3 Global Angiotensin II Receptor Sales Estimates and Forecasts 2021-2032
- 3.4 Global Angiotensin II Receptor Sales by Region
- 3.4.1 Global Angiotensin II Receptor Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Angiotensin II Receptor Sales by Region (2021-2026)
- 3.4.3 Global Angiotensin II Receptor Sales by Region (2027-2032)
- 3.4.4 Global Angiotensin II Receptor Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Angiotensin II Receptor Revenue by Manufacturers
- 4.1.1 Global Angiotensin II Receptor Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Angiotensin II Receptor Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Angiotensin II Receptor Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Angiotensin II Receptor Sales by Manufacturers
- 4.2.1 Global Angiotensin II Receptor Sales by Manufacturers (2021-2026)
- 4.2.2 Global Angiotensin II Receptor Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Angiotensin II Receptor Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Angiotensin II Receptor Sales Price by Manufacturers (2021-2026)
- 4.4 Global Angiotensin II Receptor Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Angiotensin II Receptor Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Angiotensin II Receptor Manufacturers, Product Type & Application
- 4.7 Global Angiotensin II Receptor Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Angiotensin II Receptor Market CR5 and HHI
- 4.8.2 2025 Angiotensin II Receptor Tier 1, Tier 2, and Tier 3
5 Angiotensin II Receptor Market by Type
- 5.1 Global Angiotensin II Receptor Revenue by Type
- 5.1.1 Global Angiotensin II Receptor Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Angiotensin II Receptor Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Angiotensin II Receptor Revenue Market Share by Type (2021-2032)
- 5.2 Global Angiotensin II Receptor Sales by Type
- 5.2.1 Global Angiotensin II Receptor Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Angiotensin II Receptor Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Angiotensin II Receptor Sales Market Share by Type (2021-2032)
- 5.3 Global Angiotensin II Receptor Price by Type
6 Angiotensin II Receptor Market by Application
- 6.1 Global Angiotensin II Receptor Revenue by Application
- 6.1.1 Global Angiotensin II Receptor Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Angiotensin II Receptor Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Angiotensin II Receptor Revenue Market Share by Application (2021-2032)
- 6.2 Global Angiotensin II Receptor Sales by Application
- 6.2.1 Global Angiotensin II Receptor Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Angiotensin II Receptor Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Angiotensin II Receptor Sales Market Share by Application (2021-2032)
- 6.3 Global Angiotensin II Receptor Price by Application
7 Company Profiles
- 7.1 CJ HealthCare Corp
- 7.1.1 CJ HealthCare Corp Company Information
- 7.1.2 CJ HealthCare Corp Business Overview
- 7.1.3 CJ HealthCare Corp Angiotensin II Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 CJ HealthCare Corp Angiotensin II Receptor Product Portfolio
- 7.1.5 CJ HealthCare Corp Recent Developments
- 7.2 MorphoSys AG
- 7.2.1 MorphoSys AG Company Information
- 7.2.2 MorphoSys AG Business Overview
- 7.2.3 MorphoSys AG Angiotensin II Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 MorphoSys AG Angiotensin II Receptor Product Portfolio
- 7.2.5 MorphoSys AG Recent Developments
- 7.3 Vicore Pharma AB
- 7.3.1 Vicore Pharma AB Company Information
- 7.3.2 Vicore Pharma AB Business Overview
- 7.3.3 Vicore Pharma AB Angiotensin II Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Vicore Pharma AB Angiotensin II Receptor Product Portfolio
- 7.3.5 Vicore Pharma AB Recent Developments
- 7.4 Novartis AG
- 7.4.1 Novartis AG Company Information
- 7.4.2 Novartis AG Business Overview
- 7.4.3 Novartis AG Angiotensin II Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Novartis AG Angiotensin II Receptor Product Portfolio
- 7.4.5 Novartis AG Recent Developments
8 North America
- 8.1 North America Angiotensin II Receptor Market Size by Type
- 8.1.1 North America Angiotensin II Receptor Revenue by Type (2021-2032)
- 8.1.2 North America Angiotensin II Receptor Sales by Type (2021-2032)
- 8.1.3 North America Angiotensin II Receptor Price by Type (2021-2032)
- 8.2 North America Angiotensin II Receptor Market Size by Application
- 8.2.1 North America Angiotensin II Receptor Revenue by Application (2021-2032)
- 8.2.2 North America Angiotensin II Receptor Sales by Application (2021-2032)
- 8.2.3 North America Angiotensin II Receptor Price by Application (2021-2032)
- 8.3 North America Angiotensin II Receptor Market Size by Country
- 8.3.1 North America Angiotensin II Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Angiotensin II Receptor Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Angiotensin II Receptor Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Angiotensin II Receptor Market Size by Type
- 9.1.1 Europe Angiotensin II Receptor Revenue by Type (2021-2032)
- 9.1.2 Europe Angiotensin II Receptor Sales by Type (2021-2032)
- 9.1.3 Europe Angiotensin II Receptor Price by Type (2021-2032)
- 9.2 Europe Angiotensin II Receptor Market Size by Application
- 9.2.1 Europe Angiotensin II Receptor Revenue by Application (2021-2032)
- 9.2.2 Europe Angiotensin II Receptor Sales by Application (2021-2032)
- 9.2.3 Europe Angiotensin II Receptor Price by Application (2021-2032)
- 9.3 Europe Angiotensin II Receptor Market Size by Country
- 9.3.1 Europe Angiotensin II Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Angiotensin II Receptor Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Angiotensin II Receptor Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Angiotensin II Receptor Market Size by Type
- 10.1.1 China Angiotensin II Receptor Revenue by Type (2021-2032)
- 10.1.2 China Angiotensin II Receptor Sales by Type (2021-2032)
- 10.1.3 China Angiotensin II Receptor Price by Type (2021-2032)
- 10.2 China Angiotensin II Receptor Market Size by Application
- 10.2.1 China Angiotensin II Receptor Revenue by Application (2021-2032)
- 10.2.2 China Angiotensin II Receptor Sales by Application (2021-2032)
- 10.2.3 China Angiotensin II Receptor Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Angiotensin II Receptor Market Size by Type
- 11.1.1 Asia Angiotensin II Receptor Revenue by Type (2021-2032)
- 11.1.2 Asia Angiotensin II Receptor Sales by Type (2021-2032)
- 11.1.3 Asia Angiotensin II Receptor Price by Type (2021-2032)
- 11.2 Asia Angiotensin II Receptor Market Size by Application
- 11.2.1 Asia Angiotensin II Receptor Revenue by Application (2021-2032)
- 11.2.2 Asia Angiotensin II Receptor Sales by Application (2021-2032)
- 11.2.3 Asia Angiotensin II Receptor Price by Application (2021-2032)
- 11.3 Asia Angiotensin II Receptor Market Size by Country
- 11.3.1 Asia Angiotensin II Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Angiotensin II Receptor Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Angiotensin II Receptor Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Angiotensin II Receptor Market Size by Type
- 12.1.1 SAMEA Angiotensin II Receptor Revenue by Type (2021-2032)
- 12.1.2 SAMEA Angiotensin II Receptor Sales by Type (2021-2032)
- 12.1.3 SAMEA Angiotensin II Receptor Price by Type (2021-2032)
- 12.2 SAMEA Angiotensin II Receptor Market Size by Application
- 12.2.1 SAMEA Angiotensin II Receptor Revenue by Application (2021-2032)
- 12.2.2 SAMEA Angiotensin II Receptor Sales by Application (2021-2032)
- 12.2.3 SAMEA Angiotensin II Receptor Price by Application (2021-2032)
- 12.3 SAMEA Angiotensin II Receptor Market Size by Country
- 12.3.1 SAMEA Angiotensin II Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Angiotensin II Receptor Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Angiotensin II Receptor Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Angiotensin II Receptor Value Chain Analysis
- 13.1.1 Angiotensin II Receptor Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Angiotensin II Receptor Production Mode & Process
- 13.2 Angiotensin II Receptor Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Angiotensin II Receptor Distributors
- 13.2.3 Angiotensin II Receptor Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst